Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases - PubMed (original) (raw)
Review
Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases
Ping Wu et al. Brain Res Bull. 2013 Aug.
Abstract
Long noncoding RNAs (lncRNAs) have been attracting immense research interest, while only a handful of lncRNAs have been characterized thoroughly. Their involvement in the fundamental cellular processes including regulate gene expression at epigenetics, transcription, and post-transcription highlighted a central role in cell homeostasis. However, lncRNAs studies are still at a relatively early stage, their definition, conservation, functions, and action mechanisms remain fairly complicated. Here, we give a systematic and comprehensive summary of the existing knowledge of lncRNAs in order to provide a better understanding of this new studying field. lncRNAs play important roles in brain development, neuron function and maintenance, and neurodegenerative diseases are becoming increasingly evident. In this review, we also highlighted recent studies related lncRNAs in central nervous system (CNS) development and neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS), and elucidated some specific lncRNAs which may be important for understanding the pathophysiology of neurodegenerative diseases, also have the potential as therapeutic targets.
Keywords: 5′-bromo-uridine immunoprecipitation chase followed by deep sequencing; AD; ALS; APP; Alzheimer's disease; Aβ40; Aβ42; BACE1; BC1; BC200 (BCYRN1); BDNF; BRIC–Seq; CHIRP-Seq; CNS; Ca(2+)/calmodulin-dependent protein kinase II; CaMKII; Camk2n1; DJ-1 (PARK7); DNA-binding domain protein 43; ENORs; Expression signature; FUS/TLS; GDNFOS; Gad1; Gene Nomenclature Committee; HAR1; HD; HGNCHOTAIRM1; HOX antisense intergenic RNA myeloid 1; HTTAS; HUGO; Huntingtin antisense; Huntington's disease; ISH; LRRK2; LTD; LTP; Malat1; NAT-Rad18; NO; NOSs; NTAs; Neurodegenerative disease; Neuron; Nitric oxide; Nkx2.2 AS; Nkx2.2 antisense; Noncoding RNA; Nrgn; ORF; PCG; PD; PINK1; PRC2; Parkinson disease protein 7; Parkinson's disease; RE1-silencing transcription factor/neuron-restrictive silencer factor; REST/NRSF; RIP-Chip; RNCR2; RNP immunoprecipitation-microarray; SAGE; SOX2; SRY (sex determining region Y)-box 2; Shh; Six3 opposite strand; Six3OS; Sox2 overlapping transcript; Sox2OT; TDP43TAR; TUG1; X-inactive specific transcript; Xist; amyloid precursor protein; amyloid-β-40; amyloid-β-42; amyotrophic lateral sclerosis; brain cytoplasmic RNA 1; brain derived neurotrophic factor; c-KLAN; calcium/calmodulin-dependent protein kinase II inhibitor 1; catRAPID; central nervous system; chromatin isolation by RNA purification followed by deep sequencing; combined knockdown and localization analysis of noncoding RNAs; eIF4A; eukaryotic initiation factor 4A; expressed noncoding regions; fast predictions of RNA and protein interactions and domains; fused in sarcoma/translated in liposarcoma; glial cell derived neurotrophic factor opposite strand; glutamate decarboxylase 1; human accelerated regions 1; iPSC; in situ hybridization; induced pluripotent stem cells; large intergenic noncoding RNAs; leucine-rich repeat kinase 2; lincRNAs; lncRNA; lncRNAs; long noncoding RNAs; long-term depression; long-term potentiation; metastasis-associated lung adenocarcinoma transcript 1; natural antisense RNAs; natural antisense-Rad 18; ncRNAs; neurogranin; nitric oxide synthases; noncoding RNAs; open reading frame; phosphatase and tensin homologue induced putative kinase 1; polycomb repressive complex 2; protein coding gene; retinal noncoding RNA 2; serial analysis of gene expression; sonic hedgehog; taurine upregulated gene 1; wilde type Cu/Zn superoxide dismutase; wtSOD1; β-site amyloid precursor protein-cleaving enzyme.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Long non-coding RNAs: a new frontier in the study of human diseases.
Shi X, Sun M, Liu H, Yao Y, Song Y. Shi X, et al. Cancer Lett. 2013 Oct 10;339(2):159-66. doi: 10.1016/j.canlet.2013.06.013. Epub 2013 Jun 18. Cancer Lett. 2013. PMID: 23791884 Review. - Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Łos MJ. Ghavami S, et al. Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Prog Neurobiol. 2014. PMID: 24211851 Review. - The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis.
Riva P, Ratti A, Venturin M. Riva P, et al. Curr Alzheimer Res. 2016;13(11):1219-1231. doi: 10.2174/1567205013666160622112234. Curr Alzheimer Res. 2016. PMID: 27338628 Review. - Long non-coding RNAs: From disease code to drug role.
Chen Y, Li Z, Chen X, Zhang S. Chen Y, et al. Acta Pharm Sin B. 2021 Feb;11(2):340-354. doi: 10.1016/j.apsb.2020.10.001. Epub 2020 Oct 10. Acta Pharm Sin B. 2021. PMID: 33643816 Free PMC article. Review. - Targeting long non-coding RNAs in cancers: progress and prospects.
Li CH, Chen Y. Li CH, et al. Int J Biochem Cell Biol. 2013 Aug;45(8):1895-910. doi: 10.1016/j.biocel.2013.05.030. Epub 2013 Jun 4. Int J Biochem Cell Biol. 2013. PMID: 23748105 Review.
Cited by
- Neighboring gene regulation by antisense long non-coding RNAs.
Villegas VE, Zaphiropoulos PG. Villegas VE, et al. Int J Mol Sci. 2015 Feb 3;16(2):3251-66. doi: 10.3390/ijms16023251. Int J Mol Sci. 2015. PMID: 25654223 Free PMC article. Review. - Long non-coding RNA Malat1 promotes neurite outgrowth through activation of ERK/MAPK signalling pathway in N2a cells.
Chen L, Feng P, Zhu X, He S, Duan J, Zhou D. Chen L, et al. J Cell Mol Med. 2016 Nov;20(11):2102-2110. doi: 10.1111/jcmm.12904. Epub 2016 Jul 4. J Cell Mol Med. 2016. PMID: 27374227 Free PMC article. - Zinc as a Mediator Through the ROCK1 Pathway of Cognitive Impairment in Aluminum-Exposed Workers: A Clinical and Animal Study.
Shang N, Li X, Zhang L, Wang S, He C, Zhang L, Niu Q, Zheng X. Shang N, et al. Biol Trace Elem Res. 2024 Dec;202(12):5413-5428. doi: 10.1007/s12011-024-04119-2. Epub 2024 Feb 26. Biol Trace Elem Res. 2024. PMID: 38407795 - SSS-test: a novel test for detecting positive selection on RNA secondary structure.
Walter Costa MB, Höner Zu Siederdissen C, Dunjić M, Stadler PF, Nowick K. Walter Costa MB, et al. BMC Bioinformatics. 2019 Mar 21;20(1):151. doi: 10.1186/s12859-019-2711-y. BMC Bioinformatics. 2019. PMID: 30898084 Free PMC article. - Role of long non-coding RNA H19 in the development of osteoporosis.
Chen S, Liu D, Zhou Z, Qin S. Chen S, et al. Mol Med. 2021 Sep 28;27(1):122. doi: 10.1186/s10020-021-00386-0. Mol Med. 2021. PMID: 34583640 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous